BioNTech SE ADR (NASDAQ: BNTX) is 1.48% higher on its value in year-to-date trading and has touched a low of $76.53 and a high of $131.49 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BNTX stock was last observed hovering at around $113.10 in the last trading session, with the day’s gains setting it 2.54%.
Currently trading at $115.64, the stock is 17.92% and 17.52% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.22 million and changing 2.25% at the moment leaves the stock 7.09% off its SMA200. BNTX registered 17.10% gain for a year compared to 6-month loss of -4.21%. The firm has a 50-day simple moving average (SMA 50) of $97.9961 and a 200-day simple moving average (SMA200) of $107.8287.
The stock witnessed a 10.20% gain in the last 1 month and extending the period to 3 months gives it a 5.46%, and is 17.34% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.86% over the week and 4.83% over the month.
BioNTech SE ADR (BNTX) has around 6772 employees, a market worth around $27.80B and $2.97B in sales. Profit margin for the company is -27.39%. Distance from 52-week low is 51.10% and -12.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.93%).
with sales reaching $143.61M over the same period.The EPS is expected to shrink by -75.17% this year, but quarterly earnings will post -21.41% year-over-year. Quarterly sales are estimated to grow 11.59% in year-over-year returns.
BioNTech SE ADR (BNTX) Top Institutional Holders
479.0 institutions hold shares in BioNTech SE ADR (BNTX), with institutional investors hold 59.64% of the company’s shares. The shares outstanding are 240.39M, and float is at 236.70M with Short Float at 2.27%. Institutions hold 22.25% of the Float.
The top institutional shareholder in the company is BAILLIE GIFFORD & CO with over 8.28 million shares valued at $665.08 million. The investor’s holdings represent 3.4425% of the BNTX Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 4.79 million shares valued at $$384.89 million to account for 1.9922 of the shares outstanding. The other top investors are FLOSSBACH VON STORCH AG which holds 4.38 million shares representing 1.8216% and valued at over $351.94 million, while HARDING LOEVNER LP holds 1.2174 of the shares totaling 2.93 million with a market value of $235.22 million.
BioNTech SE ADR (BNTX) Insider Activity
#####
Still, SEC filings show that on May 07 ’25, Jeggle Helmut Wolfgang (Director) Proposed Sale 150,000 shares at an average price of $94.74 for $14.21 million. The insider now directly holds shares of BioNTech SE ADR (BNTX).
